Modern Veterinary Therapeutics is a privately held international veterinary pharmaceutical company founded in Miami by Dr. Cuong Tu Ba, a French Veterinarian.
We are a research driven company that devotes our energy to the research and development of innovative veterinary pharmaceuticals, biologics and diagnostics. Modern Veterinary Therapeutics products are recognized by veterinarians for their high quality standards.
Modern Veterinary Therapeutics’ mission is to provide high quality products to the veterinary industry to promote the health and well-being of companion and production animals.
Our products are registered in three key markets: United States, Canada, and Australia.
Modern Veterinary Therapeutics, LLC. is aggressively developing a rich pipeline of pharmaceutical products in the respiratory, anesthetic, critical care, pain management, sedative, osteoarthritis, antibiotics and behavior therapeutic areas.
Pharmaceuticals, Biologics, Diagnostics, Pain Management, Behavior Therapeutics
CEPETOR, our canine sedative and analgesic, and REVERTOR, our reversing agent, are prominent products in the small animal markets. CEPESEDAN, our equine sedative and analgesic, and RESPIPULMIN, our equine bronchodilator, are reputable among the equine market. CLOPROSTENOL VEYX, our sterile synthetic prostaglandin, is the first to launch in our cattle product line, along with HYMATIL, the first generic tilmicosin injection. Our four newest product launches are KETOPROFEN V, anti-inflammatory analgesic (NSAID), for cattle, swine, and horses, NERFASIN 20, sedative/analgesic/muscle relaxer for dogs, cats, and cattle, NERFASIN 100, sedative/analgesic/muscle relaxer for horses, and Cloprostenol Veyx SW, our sterile synthetic prostaglandin for swine.
Our diagnostic test kit line includes the Canine Heartworm Antigen Test Kit, ONE STEP Canine Heartworm Antigen Test Kit, Canine Parvovirus Antigen Test Kit, and Canine Parvovirus-Coronavirus Antigen Test Kit.